Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.30 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.30 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.30 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.30 |
| ▸ | EDNRB | P24530 | 1/20 | 0.30 |
| ▸ | EDNRA | P25101 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24006319 | 1.00 | KDM4E (0.34) | KDM4EATML3MBTL1HDAC4AKR1C4 | |
| SCHEMBL26018169 | 0.99 | KDM4E (0.33) | KDM4EATML3MBTL1HDAC4 | |
| SCHEMBL19360292 | 0.99 | KDM4E (0.35) | KDM4EATML3MBTL1 | |
| SCHEMBL24160350 | 0.98 | KDM4E (0.35) | KDM4EATML3MBTL1 | |
| SCHEMBL26011924 | 0.97 | KDM4E (0.35) | KDM4EATML3MBTL1HDAC4AKR1C4 | |
| SCHEMBL18410797 | 0.96 | KDM4E (0.33) | KDM4EATML3MBTL1HDAC4AKR1C4 | |
| SCHEMBL25806140 | 0.95 | JAK2 (0.31) | — | |
| SCHEMBL22737992 | 0.95 | L3MBTL1 (0.38) | KDM4EATML3MBTL1HDAC4AKR1C4 | |
| SCHEMBL21128999 | 0.94 | KDM4E (0.30) | KDM4EATML3MBTL1 | |
| SCHEMBL23383677 | 0.94 | USP2 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230200229-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230200229-A1 | ORGANIC LIGHT EMITTING DEVICE | CTNNB1, CYBA, CRY1 | KDM4E 2651/4885ATM 2193/4885L3MBTL1 899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.